Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

PTGX holding history

Protagonist Therapeutics, Inc in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PTGX overviewAll 13F holders of PTGXFull Q2 2026 holdings

Shares (Q2 2026)
10,878
Value
$1.33M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of PTGX by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,878$1.33M<0.1%−1,040−8.7%ReducedHolders
Q1 202611,918$1.26M<0.1%−2,166−15.4%ReducedHolders
Q4 202514,084$1.23M<0.1%+897+6.8%AddedHolders
Q3 202513,187$876.0K<0.1%−2,189−14.2%ReducedHolders
Q2 202515,376$849.8K<0.1%−1,382−8.2%ReducedHolders
Q1 202516,758$810.4K<0.1%−3,699−18.1%ReducedHolders
Q4 202420,457$789.6K<0.1%+4,776+30.5%AddedHolders
Q3 202415,681$705.6K<0.1%+4,411+39.1%AddedHolders
Q2 202411,270$390.5K<0.1%−3,075−21.4%ReducedHolders
Q1 202414,345$415.0K<0.1%+1,206+9.2%AddedHolders
Q4 202313,139$301.3K<0.1%+1,957+17.5%AddedHolders
Q3 202311,182$186.5K<0.1%+427+4.0%AddedHolders
Q2 202310,755$297.1K<0.1%+1,869+21.0%AddedHolders
Q1 20238,886$204.4K<0.1%+8,886NewHolders
Q2 20220$00.0%−13,399−100.0%Sold outHolders
Q1 202213,399$317.0K<0.1%−3,090−18.7%ReducedHolders
Q4 202116,489$564.0K<0.1%+597+3.8%AddedHolders
Q3 202115,892$282.0K<0.1%−2,729−14.7%ReducedHolders
Q2 202118,621$836.0K<0.1%+3,254+21.2%AddedHolders
Q1 202115,367$398.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.